Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 5
2016 2
2018 3
2019 4
2020 8
2021 9
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
Gottardi M, Simonetti G, Sperotto A, Nappi D, Ghelli Luserna di Rorà A, Padella A, Norata M, Giannini MB, Musuraca G, Lanza F, Cerchione C, Martinelli G. Gottardi M, et al. Among authors: ghelli luserna di rora a. Cancers (Basel). 2021 Sep 11;13(18):4566. doi: 10.3390/cancers13184566. Cancers (Basel). 2021. PMID: 34572794 Free PMC article. Review.
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future.
Gottardi M, Sperotto A, Ghelli Luserna Di Rorà A, Padella A, Cangini D, Giannini MB, Simonetti G, Martinelli G, Cerchione C. Gottardi M, et al. Among authors: ghelli luserna di rora a. Minerva Med. 2020 Oct;111(5):395-410. doi: 10.23736/S0026-4806.20.07019-6. Epub 2020 Sep 21. Minerva Med. 2020. PMID: 32955828 Free article. Review.
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Ghetti M, Vannini I, Bochicchio MT, Azzali I, Ledda L, Marconi G, Melloni M, Fabbri F, Rondoni M, Chicchi R, Angeli D, Ghelli Luserna di Rorà A, Giannini B, Zacheo I, Biguzzi R, Lanza F, Martinelli G, Simonetti G. Ghetti M, et al. Among authors: ghelli luserna di rora a. Biomed Pharmacother. 2023 Sep;165:115235. doi: 10.1016/j.biopha.2023.115235. Epub 2023 Aug 1. Biomed Pharmacother. 2023. PMID: 37536029 Free article.
Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations.
Ferrari A, Cangini D, Ghelli Luserna di Rorà A, Condorelli A, Pugliese M, Schininà G, Cosentino S, Fonzi E, Domizio C, Simonetti G, Leotta S, Milone G, Martinelli G. Ferrari A, et al. Among authors: ghelli luserna di rora a. Front Cell Dev Biol. 2023 May 23;11:1165308. doi: 10.3389/fcell.2023.1165308. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37287455 Free PMC article.
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
Martino M, Canale FA, Alati C, Vincelli ID, Moscato T, Porto G, Loteta B, Naso V, Mazza M, Nicolini F, Ghelli Luserna di Rorà A, Simonetti G, Ronconi S, Ceccolini M, Musuraca G, Martinelli G, Cerchione C. Martino M, et al. Among authors: ghelli luserna di rora a. Cancers (Basel). 2021 May 27;13(11):2639. doi: 10.3390/cancers13112639. Cancers (Basel). 2021. PMID: 34072068 Free PMC article. Review.
Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
Ferrari A, Ghelli Luserna Di Rora A, Domizio C, Papayannidis C, Simonetti G, Maria Hernández-Rivas J, Rondoni M, Giglio F, Abruzzese E, Imovilli A, Iacobucci I, Calistri D, Martinelli G. Ferrari A, et al. Among authors: ghelli luserna di rora a. Br J Haematol. 2021 Mar;192(6):e139-e144. doi: 10.1111/bjh.17265. Epub 2020 Dec 13. Br J Haematol. 2021. PMID: 33314053 Free article. Clinical Trial. No abstract available.
36 results